Gout EBM Mark Lepsch 7292009 - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Gout EBM Mark Lepsch 7292009

Description:

Gout - Overview ... 85-90% of patients w/ gout will have podagra at some point in their life. ... Any hx of symptoms of gout, especially w/ worsening renal function ... – PowerPoint PPT presentation

Number of Views:219
Avg rating:3.0/5.0
Slides: 25
Provided by: HSC75
Category:
Tags: ebm | gout | lepsch | mark

less

Transcript and Presenter's Notes

Title: Gout EBM Mark Lepsch 7292009


1
Gout - EBMMark Lepsch7/29/2009
2
Case 1
  • A 31 year old family medicine resident presents
    to your clinic to discuss hair care products for
    his white mans afro. Additionally, he
    mentions that he has been struggling to reconcile
    the teachings he learned in medical school about
    under-excreters verus over-producers for
    gouty arthritis. He wants to know what the
    evidence is behind the workup and treatment, and
    how he should approach this clinical problem in
    the future.

Answer Soul Glo see Coming to America w/
Eddie Murphy for details.
3
Gout - EBM
  • Overview Pathology, Etiology, Epidemiology
  • Overview Old School Teaching for Workup and
    RX
  • Break into groups Construct plan for workup and
    Rx of a case, support with evidence.
  • Reconvene compare group results w/ Level H
    evidence.
  • Group Hug

4
Gout - Overview
  • Acute, intense, inflammatory monoarthritis caused
    by deposition of MSU (monosodium urate) crystals
    in a joint.
  • Hyperuricemia (inc. uric acid) at some point is
    necessary, but not sufficient for diagnosis, as
    60 of people w/ elevated uric acid will never
    have an attack of gout.
  • Onset usually after age 30 in men, after age 45
    in women.
  • Men 8x women before menopause.
  • Men 3x women after menopause.
  • Gouty attacks are possible when serum uric acid
    levels are normal.

5
Gout DDX
Trauma Infection (Strep, Staph, Gonorrhea) Gouty
Arthritis CPPD (Calcium pyrophosphate deposition
disease), aka Pseudogout Osteoarthritis Rheumatoid
Arthritis
6
Gout - Biochemistry
  • Allopurinol Alloxanthine (t1/218-30hrs)
  • -
  • Purines Xanthine Oxidase
  • HypoXanthine Xanthine Urate (deposits in
  • tissues as MSU crystals)
  • Precipitation of MSU crystals level 8.0mg/dL
  • Hyperuricemia level 7.0mg/dL
  • Uric Acid Goal for Patients w/ Gout level 5-6mg/dL

7
Gout Overproducers vs. Underexcreters
  • Normal daily uric acid production 600mg/day
  • Overproducer Person who excretes 800mg/day
  • Assuming normal renal function and regular diet
    (no excessive purines)
  • 60-80 of Uric acid is excreted renally.
  • 20-40 of Uric acid is eliminated by GI tract.
  • 90 of patients w/ primary gout have defects w/
    renal excretion of uric acid, thus 90 are
    Underexcreters.
  • Uric acid filtered by glomeruli, resorbed in
    PCT, secreted in DCT

8
Gout - Etiology
  • Purine rich foods meat, kidney, liver, seafood,
    anchovies, oatmeal, certain vegetables (peas,
    beans, lentils, mushrooms, cauliflower, spinach),
    sweetbreads
  • ETOH, Caffeine
  • Drugs HCTZ, loop diuretics, NSAIDs,
    corticosteroids, Niacin, Sinemet, Cyclosporine,
    Salicylates, Ethambutol, Pyrazinamide
  • Trauma
  • Infection
  • Other disease DM, HTN, vascular dx, renal dx,
    thyroid dx, sarcoidosis, etc.

9
Gout History
  • 90 present with acute, inflammatory, severe
    monoarticular pain.
  • 50 present with podagra (inflammation of 1st
    MTP joint - big toe). Likely because MTP is
    susceptible to trauma and cooling
    (crystallization of MSU). 85-90 of patients w/
    gout will have podagra at some point in their
    life.
  • Pain is so severe that patients cannot even
    tolerate a bedsheet on the affected joint.
  • Abrupt dietary changes, i.e. acute fluctuations
    in purine intake.
  • Peak of attack usually in 1-2 days, may last 7-10
    days if untreated.
  • Why at Night? Water is reabsorbed from joint
    spaces, leaving supersaturated MSU
    concentrations.

10
Gout PE
  • Rubor
  • Tumor
  • Dolor
  • Gouty tophi

11
Gouty Tophi
Tophi masses of MSU crystals deposited in the
soft tissues (or bones) of body. Most commonly
in base of great toe, fingers wrist, hand,
olecranon bursae, or Achilles tendon.
12
Acute Gout Workup
  • Establish diagnosis w/ arthroscopy looking for
    MSU crystals (yellow, parallel, allopurinol)
  • Needle shaped
  • Negatively birefringent on polarized light
    microscopy
  • From AAFP 4/1999
  • Baseline labs should include BMP, U/A, CBC, and
    serum Uric Acid.

13
Microscopy for MSU Crystals
14
Acute Gout - Rx
  • NSAIDs (unless CRI, CHF, PUD, etc.)

- Indomethacin 50mg tid - Naproxen 825mg once,
then 275 q8hr - Sulindac 200mg bid
Corticosteroids (Intra-articular if one joint,
systemic if multiple joints)
- 20-30mg/day if systemic used
- Most beneficial in first 12-36 hours of an
attack - 1mg initially, then 0.5mg qhr until
either symptoms relieved or GI side fx
(N/V/diarrhea) or 7mg total given - Renal
dosing - If Cr clearance If Cr clearance
Colchicine (adjust dose in patients w/ renal
insufficiency)
15
Intercritical Gout - Rx
Education, Lifestyle/Diet modification,
Pharmacotherapy modification
Allopurinol toxicity?
Allopurinol therapy if - Recurrent attacks
despite diet chg/etc. - Hx of nephrolithiasis -
Serum creatinine 2.0 - Serum uric acid
11.0 - 24 hr urine uric acid 800mg/dL - Tophi
present
Colchicine
  • Failing therapy?

Probenecid if - Recurrent attacks and 24hr
urine uric acid
16
Asymptomatic Hyperuricemia
  • Indications for Rx include
  • 24hr Urinary Uric Acid Excretion 1100mg
  • Serum uric acid Men 13mg/dL, Women 10mg/dL
  • Nephrolithiasis
  • Any hx of symptoms of gout, especially w/
    worsening renal function
  • Presence of gouty tophi in bone or soft tissues
  • Radiographic signs of gouty arthritis
  • Impending chemotherapy or radiotherapy for
    leukemia or lymphoma

17
Gouty Arthritis - Radiographs
18
Case
  • A 57 y.o. AA male w/ hx of HTN, DM (elevated FPG
    2 years ago, pt. lost to follow up), and self
    reported hx of the gout presents to your clinic
    with intermittent knee pain for the last year,
    now severe for the last week. Patient has
    history of intermittent compliance w/ medicines
    (HCTZ 25, Atenolol 25), pt. has occasional
    episodes of binge drinking (beer), pt. does not
    smoke. Pt. has been seen a total of 3 times in
    the last 10 years and has not had any
    preventative health screening. He is a
    self-paying patient who works construction
    (mostly concrete) and does often kneel on hard
    surfaces, but wears knee-pads. He denies any
    specific trauma or prior knee injuries. He says
    he has had a prior episode of podagra years ago
    but no arthrocentesis was ever done. He was
    prescribed Allopurinol 5 years ago but has never
    taken it. All other hx negative.
  • PE BP 172/98. R knee warm, red, swollen, no
    breaks in skin, tender w/ flexion/extension,
    antalgic gait.
  • Question What do you do today in clinic (1)
    Diagnostics (2) Rx? be specific, include
    dosages.

19
Case
  • Pt. returns in 2 weeks to your clinic. His labs
    were as follows
  • - CBC normal
  • - BMP notable for Glucose 220, BUN 27, Creatinine
    1.7, else nl
  • - U/A 1 protein, TR LE, TR blood
  • - Serum Uric Acid 8.4mg/dL
  • - Knee fluid notable for negatively bi-refringent
    crystals
  • The patient took Indomethacin 50mg tid for 3
    days, then has been taking it prn (between 0 and
    2 times a day). His knee pain is now a 4/10
    (down from an 8/10). He is ambulating with only
    a mildly antalgic gait. His knee is
    normotensive, not swollen, and only mildly tender
    to flexion/extension.
  • Question What do you do today in clinic (1)
    Diagnostics (2) Rx? be specific, include
    dosages.

20
Allopurinol
  • Trade name Zyloprim
  • 300mg daily reduces serum urate patients
  • Renal dosing
  • CrCl 40-60, max of 200mg/day
  • CrCl 20-40, max of 150mg/day
  • CrCl 10-20, max of 100mg/day
  • CrCl
  • Toxicities include
  • Skin rash, potentially Stevens-Johnson and TEN
  • Leukopenia
  • GI intolerance
  • Initiation can precipitate gout attack

21
Colchicine
  • Mechanism binds to microtubules, blocks
    phagocytosis of uric acid crystals by PMNs,
    blocks release of chemotactic factor thus
    decreasing inflammatory response.
  • Works best early in attack once inflammation
    exists it is less effective
  • Side fx include
  • GI intolerance
  • Bone marrow suppression
  • Renal damage
  • Hepatic damage
  • Axonal neuropathy
  • Irreversible azospermia

22
Probenecid
  • Trade name Benemid
  • Typical dosing
  • Start 500mg bid, max of 2-3g/day
  • Dose of 1-2g/day achieves control in 60-85 of
    patients
  • Renal dosing
  • Contraindicated if hx of nephrolithiasis or CrCl
  • Use limited by physiologic decline in CrCl w/
    aging
  • Side fx include
  • GI intolerance
  • Aplastic anemia, Hemolytic anemia, Hepatic
    necrosis
  • Blocks excretion of other organic acids, thus may
    increase plasma concentrations of PCN,
    Cephalosporins, Sulfonamides, and Indomethacin

23
Indomethacin
  • 10-40x more potent anti-inflammatory than ASA
  • Side fx
  • CNS effects (HA, dizzyness, confusion, tinnitus)
    in up to 50
  • GI side effects potentially severe w/ prolonged
    use (ulcers, GI bleed)

Quiz Question In what neonatal disease is this
medicine commonly used?
Answer PDA (Patent Ductus Arteriosus)
24
The End
Write a Comment
User Comments (0)
About PowerShow.com